Aberrant NSUN1 activity connects m 5 C-RNA modification to TDP-43 neurotoxicity in ALS/FTD
Life Science Alliance · 2026-01 · 9 (1) · e202503297
DOI: 10.26508/lsa.202503297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 04.11.2025. Verfasst von Melissa Parra-Torres und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular, Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dundee, UK. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, DNA-Binding Proteins, Frontotemporal Dementia, Methyltransferases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Medical Sciences, Alzheimer’s Research UK, Royal Society.
Abstract (Originalsprache)
In amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), the nuclear RNA-binding protein TDP-43 mislocalises to the cytoplasm and forms insoluble aggregates, but the mechanisms controlling this remain unclear. We define a native TDP-43 interactome in human SH-SY5Y cells and identify proteins linked to the 5-methylcytosine (m 5 C) RNA modification as highly enriched. Using a Drosophila model of TDP-43 pathology, we show that aberrant activity of m 5 C-RNA methyltransferases Nsun1 drives TDP-43–induced m 5 C-RNA hypermethylation, whereas Nsun1 down-regulation alleviates TDP-43–induced degeneration, lifespan deficits, and cytoplasmic accumulation. In human cells, TDP-43 selectively interacts with NSUN1 isoform 3 independently of RNA. Furthermore, NSUN1 is nucleolar and TDP-43 is largely nucleoplasmic, yet they interact in both compartments, suggesting functional roles beyond their predominant localisations. In ALS/FTD postmortem frontal cortex, NSUN1 isoform 3 persists, whereas the shorter isoform is reduced, suggesting that a pool of NSUN1 capable of contributing to pathological TDP-43 interactions remains in disease. These findings suggest that TDP-43 neurotoxicity is coupled to NSUN1 activation and m 5 C-RNA methylation, revealing a potential therapeutic axis in ALS/FTD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Molecular, Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dundee, UK.
- National Phenotypic Screening Centre, School of Life Sciences, University of Dundee, Dundee, UK.
- Data Analysis Group, Division of Computational Biology, School of Life Sciences, University of Dundee, Dundee, UK.
- Department of Basic and Clinical Neuroscience, London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
- London Neurodegenerative Diseases Brain Bank, SGDP Centre, PO65, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
- King's College Hospital NHS Foundation Trust, Academic Neuroscience Centre, London, UK.
ORCID-Profile: Melissa Parra-Torres, James A Gray, Alistair J Langlands, Marek Gierlinski, Andrew King, Leeanne McGurk
Förderung
- Academy of Medical Sciences
- Alzheimer’s Research UK
- Royal Society
- Alzheimer’s Society
- Target ALS
Zitieren
APA
Parra-Torres, M., Dissanayake, K., Gray, J. A., Langlands, A. J., Kucuk, R., Gierlinski, M., Troakes, C., King, A., & McGurk, L. (2026). Aberrant NSUN1 activity connects m 5 C-RNA modification to TDP-43 neurotoxicity in ALS/FTD. Life Science Alliance, 9(1), e202503297. https://doi.org/10.26508/lsa.202503297
Vancouver
Parra-Torres M, Dissanayake K, Gray JA, Langlands AJ, Kucuk R, Gierlinski M, et al. Aberrant NSUN1 activity connects m 5 C-RNA modification to TDP-43 neurotoxicity in ALS/FTD. Life Science Alliance. 2026;9(1):e202503297. doi:10.26508/lsa.202503297
BibTeX
@article{ParraTorres2026,
author = {Parra-Torres, Melissa and Dissanayake, Kumara and Gray, James A and Langlands, Alistair J and Kucuk, Ridvan and Gierlinski, Marek and Troakes, Claire and King, Andrew and McGurk, Leeanne},
title = {Aberrant NSUN1 activity connects m 5 C-RNA modification to TDP-43 neurotoxicity in ALS/FTD},
journal = {Life Science Alliance},
year = {2026},
volume = {9},
number = {1},
pages = {e202503297},
doi = {10.26508/lsa.202503297}
}
EUVIMED